Loading clinical trials...
Loading clinical trials...
The MAAIT is a randomized, controlled trial of a home intervention to reduce mouse allergen exposure in mouse allergic children with asthma and mouse allergen exposure. Participants will be randomized to either the Integrated Pest Management (IPM) Group or the Education Group. The IPM Group will receive professional mouse abatement, education, two HEPA filters, allergen-proof mattress and pillow encasements, and targeted cleaning. The Education Group will receive education about IPM at the beginning of the trial and then after completion of the trial, will receive the IPM intervention. Participants will be followed for 12 months.
Age
6 - 17 years
Sex
ALL
Healthy Volunteers
No
Johns Hopkins
Baltimore, Maryland, United States
Boston Children's
Boston, Massachusetts, United States
Start Date
November 1, 2010
Primary Completion Date
September 1, 2016
Completion Date
September 1, 2016
Last Updated
March 16, 2017
361
ACTUAL participants
Integrated Pest Management
OTHER
Education
OTHER
Lead Sponsor
Johns Hopkins University
Collaborators
NCT07219173
NCT02327897
NCT07486401
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions